Hansa Biopharma AB, "Hansa" or the "Company" (NASDAQ Stockholm: HNSA), today published its Annual and Sustainability Reports for 2024. Peter ...

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by ...

Compared with those who spent most of their time in a single room, people with heart failure with preserved ejection fraction (HFpEF) who were able to travel outside of their home without assistance ...

According to the Centers for Disease Control and Prevention, 1 in 7 adults in the United States will experience a substance use disorder during their lifetime. University of Oklahoma College of ...

CEL-SCI (CVM) announced new data has been published from its prior Phase 3 study of Multikine in newly diagnosed, treatment naive, resectable, ...

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and ...

Pearl Health, a leading provider of physician enablement and risk management technology and services, today announced that ...

As cancer rates rise in younger adults, Eyewitness News has compiled a list of resources to help assess your risk of cancer ...

The "Cell & Gene Therapies in Gastrointestinal Disorders: Therapeutic Analysis" report has been added to ResearchAndMarkets.com's offering.Both marketed therapies are prescribed when a patient has ...

But in today’s Spring Statement from the Chancellor, Rachel Reeves, showed a shocking determination to instead double down on ...

The court filing signals a shift from targeting openly trans troops to potentially investigating those who are closeted.